These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--case report and literature review. Baratta L; Afeltra A; Delfino M; De Castro S; Giorgino F; Rossi-Fanelli F Angiology; 2002; 53(4):465-70. PubMed ID: 12143954 [TBL] [Abstract][Full Text] [Related]
10. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration. Schöffski P; Ganser A; Pascheberg U; Büsche G; Gaede B; Hertenstein B Ann Hematol; 2000 Feb; 79(2):95-8. PubMed ID: 10741923 [TBL] [Abstract][Full Text] [Related]
11. Use of pegylated interferon in hypereosinophilic syndrome. Butterfield JH; Weiler CR Leuk Res; 2012 Feb; 36(2):192-7. PubMed ID: 22118911 [TBL] [Abstract][Full Text] [Related]
12. Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levels. Acaba L; Mangual A; Vélez García E Bol Asoc Med P R; 2000; 92(4-8):59-62. PubMed ID: 11143821 [TBL] [Abstract][Full Text] [Related]
13. Management of Hypereosinophilic Syndromes. Roufosse F Immunol Allergy Clin North Am; 2015 Aug; 35(3):561-75. PubMed ID: 26209900 [TBL] [Abstract][Full Text] [Related]
14. Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome. Choi C; Moller D; Tan J; Dou C; Peterson EA; Medvedev N; Dutz JP; Carruthers MN; Chen LYC Br J Haematol; 2020 Mar; 188(5):e68-e72. PubMed ID: 31721154 [No Abstract] [Full Text] [Related]
16. Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases. Ceretelli S; Capochiani E; Petrini M Ann Hematol; 1998 Oct; 77(4):161-4. PubMed ID: 9829847 [TBL] [Abstract][Full Text] [Related]
17. alpha-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Quiquandon I; Claisse JF; Capiod JC; Delobel J; Prin L Blood; 1995 Apr; 85(8):2284-5. PubMed ID: 7718904 [No Abstract] [Full Text] [Related]
18. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases]. Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716 [TBL] [Abstract][Full Text] [Related]
19. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review. Yoon TY; Ahn GB; Chang SH J Dermatol; 2000 Feb; 27(2):110-5. PubMed ID: 10721659 [TBL] [Abstract][Full Text] [Related]
20. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. Butterfield JH; Gleich GJ J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 2):1318-26. PubMed ID: 7798572 [No Abstract] [Full Text] [Related] [Next] [New Search]